These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23581530)

  • 1. 5-Oxo-ETE receptor antagonists.
    Gore V; Patel P; Chang CT; Sivendran S; Kang N; Ouedraogo YP; Gravel S; Powell WS; Rokach J
    J Med Chem; 2013 May; 56(9):3725-32. PubMed ID: 23581530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The eosinophil chemoattractant 5-oxo-ETE and the OXE receptor.
    Powell WS; Rokach J
    Prog Lipid Res; 2013 Oct; 52(4):651-65. PubMed ID: 24056189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship study of β-oxidation resistant indole-based 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE) receptor antagonists.
    Ye Q; Chourey S; Wang R; Chintam NR; Gravel S; Powell WS; Rokach J
    Bioorg Med Chem Lett; 2017 Oct; 27(20):4770-4776. PubMed ID: 28943042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the OXE receptor as a potential novel therapy for asthma.
    Powell WS; Rokach J
    Biochem Pharmacol; 2020 Sep; 179():113930. PubMed ID: 32240653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo α-hydroxylation of a 2-alkylindole antagonist of the OXE receptor for the eosinophil chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid in monkeys.
    Chourey S; Ye Q; Reddy CN; Cossette C; Gravel S; Zeller M; Slobodchikova I; Vuckovic D; Rokach J; Powell WS
    Biochem Pharmacol; 2017 Aug; 138():107-118. PubMed ID: 28476332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism and pharmacokinetics of a potent N-acylindole antagonist of the OXE receptor for the eosinophil chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE) in rats and monkeys.
    Reddy CN; Alhamza H; Chourey S; Ye Q; Gore V; Cossette C; Gravel S; Slobodchikova I; Vuckovic D; Rokach J; Powell WS
    Eur J Pharm Sci; 2018 Mar; 115():88-99. PubMed ID: 29339225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and Metabolism of Selective Oxoeicosanoid (OXE) Receptor Antagonists and Their Effects on 5-Oxo-6,8,11,14-eicosatetraenoic Acid (5-Oxo-ETE)-Induced Granulocyte Activation in Monkeys.
    Cossette C; Chourey S; Ye Q; Nagendra Reddy C; Gore V; Gravel S; Slobodchikova I; Vuckovic D; Rokach J; Powell WS
    J Med Chem; 2016 Nov; 59(22):10127-10146. PubMed ID: 27766872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosynthesis and actions of 5-oxoeicosatetraenoic acid (5-oxo-ETE) on feline granulocytes.
    Cossette C; Gravel S; Reddy CN; Gore V; Chourey S; Ye Q; Snyder NW; Mesaros CA; Blair IA; Lavoie JP; Reinero CR; Rokach J; Powell WS
    Biochem Pharmacol; 2015 Aug; 96(3):247-55. PubMed ID: 26032638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Oxo-ETE and the OXE receptor.
    Grant GE; Rokach J; Powell WS
    Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):98-104. PubMed ID: 19450703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of 5-oxo-6,8,11,14-eicosatetraenoic acid-induced activation of neutrophils and eosinophils by novel indole OXE receptor antagonists.
    Gore V; Gravel S; Cossette C; Patel P; Chourey S; Ye Q; Rokach J; Powell WS
    J Med Chem; 2014 Jan; 57(2):364-77. PubMed ID: 24351031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Highly Potent and Metabolically Resistant Oxoeicosanoid (OXE) Receptor Antagonists That Block the Actions of the Granulocyte Chemoattractant 5-Oxo-6,8,11,14-Eicosatetraenoic Acid (5-oxo-ETE).
    Chourey S; Ye Q; Reddy CN; Wang R; Cossette C; Gravel S; Slobodchikova I; Vuckovic D; Rokach J; Powell WS
    J Med Chem; 2018 Jul; 61(14):5934-5948. PubMed ID: 29972644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of allergen-induced dermal eosinophilia by an oxoeicosanoid receptor antagonist in non-human primates.
    Miller LA; Cossette C; Chourey S; Ye Q; Reddy CN; Rokach J; Powell WS
    Br J Pharmacol; 2020 Jan; 177(2):360-371. PubMed ID: 31655023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Base-dependent formation of cis and trans olefins and their application in the synthesis of 5-oxo-ETE receptor antagonists.
    Gore V; Chourey S; Ye Q; Patel P; Ouedraogo Y; Gravel S; Powell WS; Rokach J
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3385-8. PubMed ID: 24948567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A biased non-Gαi OXE-R antagonist demonstrates that Gαi protein subunit is not directly involved in neutrophil, eosinophil, and monocyte activation by 5-oxo-ETE.
    Konya V; Blättermann S; Jandl K; Platzer W; Ottersbach PA; Marsche G; Gütschow M; Kostenis E; Heinemann A
    J Immunol; 2014 May; 192(10):4774-82. PubMed ID: 24733850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eicosanoid receptors as therapeutic targets for asthma.
    Powell WS
    Clin Sci (Lond); 2021 Aug; 135(16):1945-1980. PubMed ID: 34401905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Montelukast regulates eosinophil protease activity through a leukotriene-independent mechanism.
    Langlois A; Ferland C; Tremblay GM; Laviolette M
    J Allergy Clin Immunol; 2006 Jul; 118(1):113-9. PubMed ID: 16815146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid.
    Powell WS; Rokach J
    Biochim Biophys Acta; 2015 Apr; 1851(4):340-55. PubMed ID: 25449650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel highly potent OXE receptor antagonists with prolonged plasma lifetimes that are converted to active metabolites in vivo in monkeys.
    Ye Q; Chourey S; Reddy CN; Wang R; Cossette C; Gravel S; Slobodchikova I; Vuckovic D; Rokach J; Powell WS
    Br J Pharmacol; 2020 Jan; 177(2):388-401. PubMed ID: 31655025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Lipoxygenase products regulate basophil functions: 5-Oxo-ETE elicits migration, and leukotriene B(4) induces degranulation.
    Iikura M; Suzukawa M; Yamaguchi M; Sekiya T; Komiya A; Yoshimura-Uchiyama C; Nagase H; Matsushima K; Yamamoto K; Hirai K
    J Allergy Clin Immunol; 2005 Sep; 116(3):578-85. PubMed ID: 16159627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Oxo-ETE from Nasal Epithelial Cells Upregulates Eosinophil Cation Protein by Eosinophils in Nasal Polyps in vitro.
    Lin L; Chen Z; Tang X; Dai F; Wei J; Sun G
    Int Arch Allergy Immunol; 2018; 177(2):107-115. PubMed ID: 29898459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.